A clinical case of a young patient with post-myocarditis atrial fibrillation and heart failure with reduced ejection fraction

Authors

  • Kalatsei Liudmila Department of Internal Diseases, Grodno State Medical University, Grodno, Belarus https://orcid.org/0000-0001-5211-709X
  • R. B. S. W. M. Pasan M. Kokwewa Department of Internal Diseases, Grodno State Medical University, Grodno, Belarus
  • M. M. Shalini P. Gawarammana Department of Internal Diseases, Grodno State Medical University, Grodno, Belarus https://orcid.org/0009-0003-5838-369X

DOI:

https://doi.org/10.18203/2320-6012.ijrms20254390

Keywords:

Myocarditis, Atrial fibrillation, Heart failure with reduced ejection fraction, Echocardiography, Quadruple therapy

Abstract

A clinical observation of a 26-year-old patient with post-myocarditis atrial fibrillation and heart failure (HF) with reduced left ventricular ejection fraction (LVEF) is presented. In February 2025 the patient suffered from acute myocarditis, diagnosed based on magnetic resonance imaging. The outcome was post-myocarditis cardiosclerosis complicated by HF with LVEF 28%, followed by hospitalization in a cardiology hospital. During treatment, quadruple therapy (angiotensin receptor and neprilysin inhibitor, beta-blocker, mineralocorticoid receptor antagonist, sodium-glucose cotransporter type 2 inhibitor) was initiated and sinus rhythm was restored by electrical cardioversion. This therapeutic approach resulted in significant improvements, including a regression of congestive symptoms, a natriuretic peptide level from 2530 to 267 pg/ml, and an increase in LVEF from 28% to 65%. This clinical case highlights the complexity of not only the timely diagnosis of myocarditis but also the treatment of its consequences.

Metrics

Metrics Loading ...

References

Lima MR, Custódio P, Tralhão A, Trabulo M. Case report: acute myocarditis complicated with persistent complete heart block: a clinical dilemma when myocardial inflammation remains. Eur Heart J Case Rep. 2024;8(4):ytae152. DOI: https://doi.org/10.1093/ehjcr/ytae152

Nguyen J, Benites C, Karpel D, Akram M, Concepcion L. Acute Viral Myocarditis in a Young Adult: A Case Report. Cureus. 2024;16(8):e66325.

Rottmann FA, Glück C, Kaier K, Bemtgen X, Supady A, von Zur Mühlen C, et al. Myocarditis incidence and hospital mortality from 2007 to 2022: insights from a nationwide registry. Clin Res Cardiol. 2025;114(9):1156-63. DOI: https://doi.org/10.1007/s00392-024-02494-3

Oster ME, Shay DK, Su JR, Gee J, Creech CB, Broder KR, et al. Myocarditis Cases Reported After mRNA-Based COVID-19 Vaccination in the US From December 2020 to August 2021. JAMA. 2022;327(4):331-40. DOI: https://doi.org/10.1001/jama.2021.24110

Brown J, Rashid H, Sarva ST, Tatapudi S, Kalathoor J, Srinivasan A, et al. Case Report: Three cases of clinically suspected viral myocarditis with recovery of left ventricular dysfunction. Front Cardiovasc Med. 2024;11:1345449. DOI: https://doi.org/10.3389/fcvm.2024.1345449

Rabat SK, Manzoor U, Ijaz N, Aloysius MM. A Case Report on an Underappreciated Cause of Heart Failure: Chronic Viral Myocarditis. Cureus. 2022;14(7):e27253. DOI: https://doi.org/10.7759/cureus.27253

Chabior A, Tymińska A, Pawlak A, Giordani A, Caforio A, Grabowski M, et al. Advances in myocarditis management in the light of the latest research and recent guidelines of the European Society of Cardiology. Cardiol J. 2024;31(2):342-51.

Lampejo T, Durkin SM, Bhatt N, Guttmann O. Acute myocarditis: aetiology, diagnosis and management. Clin Med (Lond). 2021;21(5):e505-10. DOI: https://doi.org/10.7861/clinmed.2021-0121

Wu L, Ji W, Huang Y, Zeng H, Chen J, Zou Y, et al. Establishment and validation of a prediction model for myocarditis in Chinese children below 14 years old: a protocol for a retrospective cohort study. BMJ Open. 2023;13(12):e075453. DOI: https://doi.org/10.1136/bmjopen-2023-075453

Caforio AL, Pankuweit S, Arbustini E, Basso C, Gimeno-Blanes J, Felix SB, et al; European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Current state of knowledge on aetiology, diagnosis, management, and therapy of myocarditis: a position statement of the European Society of Cardiology Working Group on Myocardial and Pericardial Diseases. Eur Heart J. 2013;34(33):2636-48. DOI: https://doi.org/10.1093/eurheartj/eht210

Chabior A, Tymińska A, Pawlak A, Giordani A, Caforio A, Grabowski M, et al. Advances in myocarditis management in the light of the latest research and recent guidelines of the European Society of Cardiology. Cardiol J. 2024;31(2):342-51. DOI: https://doi.org/10.5603/cj.95175

Ammirati E, Cartella I, Varrenti M, Selimi A, Sormani P, Garascia A, et al. Acute myocarditis: 2024 state of the art. Eur Heart J Suppl. 2025;27(Suppl 1):i56-60. DOI: https://doi.org/10.1093/eurheartjsupp/suae105

Nguyen J, Benites C, Karpel D, Akram M, Concepcion L. Acute Viral Myocarditis in a Young Adult: A Case Report. Cureus. 2024;16(8):e66325. DOI: https://doi.org/10.7759/cureus.66325

Downloads

Published

2025-12-30

How to Cite

Liudmila, K., Kokwewa, R. B. S. W. M. P. M., & Gawarammana, M. M. S. P. (2025). A clinical case of a young patient with post-myocarditis atrial fibrillation and heart failure with reduced ejection fraction. International Journal of Research in Medical Sciences, 14(1), 265–269. https://doi.org/10.18203/2320-6012.ijrms20254390

Issue

Section

Case Reports